SCHEMBL1646142

SCHEMBL1646142

O=[N+]([O-])c1ccc(-c2coc(-c3nc(-c4ccccc4)co3)n2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.50
▸ RAB9A P51151 3/20 0.50
▸ KMT2A Q03164 6/20 0.49
▸ MEN1 O00255 5/20 0.49
▸ MAPT P10636 4/20 0.49
▸ L3MBTL1 Q9Y468 2/20 0.49
▸ ENPP3 O14638 2/20 0.49
▸ ENPP1 P22413 2/20 0.49
▸ MMP2 P08253 2/20 0.49
▸ MMP9 P14780 2/20 0.49
▸ MMP8 P22894 2/20 0.49
▸ MMP13 P45452 2/20 0.49
▸ THRB P10828 1/20 0.48
▸ SMN1; SMN2 Q16637 4/20 0.48
▸ ALDH1A1 P00352 4/20 0.48
▸ MAPK1 P28482 2/20 0.47
▸ POLB P06746 1/20 0.47
▸ PKM P14618 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4253034 0.95 ENPP3 (0.55) NPC1RAB9AKMT2AMEN1MAPT
SCHEMBL6683781 0.95 ENPP3 (0.55) NPC1RAB9AKMT2AMEN1MAPT
SCHEMBL12797828 0.82 HSD17B1 (0.49) NPC1RAB9AKMT2AMEN1MAPT
SCHEMBL4267177 0.79 PSD (0.48) NPC1RAB9AKMT2AMEN1MAPT
SCHEMBL8119305 0.78 ENPP3 (0.59) NPC1RAB9AKMT2AMEN1MAPT
SCHEMBL3271684 0.77 ENPP3 (0.72) NPC1RAB9AKMT2AMEN1ENPP3
SCHEMBL11566150 0.77 ENPP3 (0.72) NPC1RAB9AKMT2AMEN1ENPP3
SCHEMBL28489642 0.77 MEN1 (0.60) NPC1RAB9AKMT2AMEN1MAPT
SCHEMBL6731942 0.77 MEN1 (0.60) NPC1RAB9AKMT2AMEN1MAPT
SCHEMBL5664564 0.76 ENPP3 (0.75) NPC1RAB9AKMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2303329-A1 ANTIFUNGAL COMBINATION THERAPY F2G Limited (GB) 2011-04-06 — — EP disclosed
WO-2009144473-A1 ANTIFUNGAL COMBINATION THERAPY F2G LIMITED (GB) 2009-12-03 — — WO disclosed
Send feedback